Designing a Clinical Pharmacy Primary Care Intervention for Myocardial Infarction Patients Using a Patient and Public Involvement Discussion.
clinical pharmacists
clinical pharmacy services
discharge
myocardial infarction
patient
patient and public involvement
Journal
Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532
Informations de publication
Date de publication:
24 Jan 2020
24 Jan 2020
Historique:
received:
22
10
2019
revised:
10
01
2020
accepted:
21
01
2020
entrez:
30
1
2020
pubmed:
30
1
2020
medline:
30
1
2020
Statut:
epublish
Résumé
to conduct a Patient and Public Involvement (PPI) focus group session. To help inform the design of a clinical pharmacy intervention in primary care for patients after a coronary event. this study followed a public involvement method. Community members of the public and community engaged research patients who had experienced myocardial infarction where invited to actively take part in a focus group discussion. This is to share past experiences and provide input and advice into the design of a potential research proposal. The session took place at a cardiac rehabilitation centre. four key themes were identified from the focus group these included: experiences with pharmacy and primary care services, medicines knowledge, the pharmacist role and building rapport with healthcare professionals. Nine participants and three researchers attended the PPI discussion session. Seven of the participants were patients who had experienced a cardiac event in the last three months and two were carers. Primary care pharmacy services both clinical and public health were not very familiar to the participants. Different experiences with clinical pharmacy services were reported by participants, while one experience was reported to be helpful others perceived community pharmacists to be to be busy and isolated behind a counter. A general practice GP based specialist nurse was a familiar model of care unlike a specialist clinical pharmacist GP based care role. Participants reported limited time in GP consultations and the need to book double appointments. Participants stressed the need to receive consistent information about their disease and medication from different professionals involved in their care. Different views were expressed regarding the ability to build rapport with a clinical pharmacist when compared to a GP. Input on study outcomes and design was provided by participants. participants in this session mentioned that a clinical pharmacy intervention after hospital discharge would be useful for their continuity of care. Plans are in place to continue to involve patients and the public in the write up, ethics and dissemination of the potential clinical pharmacy proposal.
Identifiants
pubmed: 31991672
pii: pharmacy8010013
doi: 10.3390/pharmacy8010013
pmc: PMC7151658
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Heart. 2002 Sep;88(3):229-33
pubmed: 12181210
Br J Clin Pharmacol. 2008 Jul;66(1):110-6
pubmed: 18492127
Health Policy. 2016 Nov;120(11):1279-1292
pubmed: 27836231
Eur J Clin Pharmacol. 2009 Nov;65(11):1071-80
pubmed: 19730842
J Gen Intern Med. 2008 Feb;23(2):115-21
pubmed: 17922172
Circulation. 2006 Jan 17;113(2):203-12
pubmed: 16401776
Circulation. 2006 Jun 20;113(24):2803-9
pubmed: 16769908
Eur Heart J. 2011 Oct;32(19):2376-86
pubmed: 21875855
Eur Heart J. 2008 Sep;29(17):2083-91
pubmed: 18664465
Healthc Pap. 2017 Oct;17(2):56-64
pubmed: 29595446